Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effects of exogenous interleukin-7 on human thymus function.

Yukari Okamoto1, Daniel C Douek, Richard D McFarland

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases and Department of Experimental Transplantation and Immunology, Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Blood
|April 4, 2002
PubMed
Summary

Interleukin-7 (IL-7) enhances T-cell receptor (TCR) rearrangement and proliferation in the thymus. This finding suggests IL-7 can boost the generation of new T-cells for immunocompromised patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgA is necessary and sufficient to prevent norovirus infection in mice.

Science translational medicine·2026
Same author

Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sites.

Science translational medicine·2026
Same author

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

NPJ vaccines·2026
Same author

SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses.

Nature communications·2026
Same author

Improving peptide vaccine manufacturability without sacrificing immunogenicity: substitution of methionine and cysteine with oxidation-resistant isosteres.

bioRxiv : the preprint server for biology·2026
Same author

The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.

Science translational medicine·2026

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Immune reconstitution is crucial for recovery from HIV, chemotherapy, and stem cell transplants.
  • Enhancing T-cell production is a key therapeutic goal for these conditions.

Purpose of the Study:

  • To investigate the effects of exogenous interleukin-7 (IL-7) on T-cell receptor (TCR) rearrangement and related processes in human thymus.
  • To determine if IL-7 can directly enhance T-cell generation.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) to measure T-cell receptor rearrangement excision circles (TRECs).
  • Thymic organ culture system to assess IL-7's impact on fetal and infant thymus.
  • In vivo experiments using NOD/LtSz-scid mice transplanted with human fetal thymus and liver.

Related Experiment Videos

Main Results:

  • TREC generation, indicating TCR rearrangement, was highest in the CD1a(+)CD3(-)CD4(+)CD8(+) thymocyte stage.
  • Exogenous IL-7 increased TREC frequency in both fetal and infant thymus, suggesting enhanced TCR rearrangement.
  • IL-7 promoted thymocyte proliferation and reduced apoptosis of immature T-cells.
  • In vivo studies indicated IL-7 directly enhances TREC generation.

Conclusions:

  • IL-7 directly increases TCR-alphabeta rearrangement in the thymus.
  • IL-7 has potential therapeutic applications for enhancing de novo naive T-cell generation in immunocompromised patients.